ABOUT SANGART
Sangart, Inc. is a privately held biopharmaceutical company focused on the research, development and commercialization of oxygen transport agents. Dr. Robert Winslow, a world-renowned authority in the field of hemoglobin and oxygen transport, founded Sangart in 1998 after having spent more than two decades studying and defining red blood cell substitutes and mechanisms of oxygen transport by cell-free hemoglobin solutions. The discoveries arising from this research form the basis for Sangart’s technologies.
Sangart’s Board of Directors includes distinguished and experienced leaders in drug development, medicine, science and business.
Sangart’s Science Advisory Board includes worldwide opinion leaders in transfusion medicine and oxygen transport.
meet the scientific advisory board
Chairman, President and
Chief Executive Officer
Chief Executive Officer
Chief Financial Officer and
General Counsel
General Counsel
Senior Vice President, Pharmaceutical Research and Development
Vice President, Business Development
Vice President, Clinical and Regulatory Affairs
Vice President, Quality
Vice President, Preclinical Research and Development